Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Revision total hip replacement arthroplasty is a surgery having intra- and postoperative substantial blood loss. The investigators will investigate the relationship between the various hematologic variables and postoperative bleeding volume.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| RTHRA group | patients undergoing revision total hip replacement |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| RTHRA group | Other | hematologic variables measurement in patients undergoing revision total hip replacement |
|
| Measure | Description | Time Frame |
|---|---|---|
| Change of FIBTEM | FIBTEM: one of the measurements of the rotational thromboelastometry | 5 minutes before initiation of anesthesia and 5 minutes after finishing operation |
| Measure | Description | Time Frame |
|---|---|---|
| volume of infused fluid during operation | Infused total crystalloid and colloid volume during the operation will be recorded | Period from starting to finishing the operation (During operation, an expected average of 3 hours) |
| intraoperative urine output |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Patients undergoing revision total hip replacement
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Hyo-Seok Na, MD, PhD | Seoul National University Bundang Hospital | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Seoul National University Bundang Hospital | Seongnam-si | Gyeonggi-do | 13620 | South Korea |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D015207 | Osteoarthritis, Hip |
| ID | Term |
|---|---|
| D010003 | Osteoarthritis |
| D001168 | Arthritis |
| D007592 | Joint Diseases |
| D009140 | Musculoskeletal Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
| Period from starting to finishing the operation (During operation, an expected average of 3 hours) |
| transfusion units | Red blood cell | Period from starting to finishing the operation (During operation, an expected average of 3 hours) and postoperative first day |
| postoperative bleeding volume | postoperative 72 hours |
| Hemoglobin | preoperative day 1 |
| Hemoglobin | postoperative day 4 |
| Hematocrit | preoperative day 1 |
| Hematocrit | postoperative day 4 |
| Platelet count | preoperative day 1 |
| Platelet count | postoperative day 4 |
| prothrombin time_international normalized ratio | preoperative day 1 |
| prothrombin time_international normalized ratio | postoperative day 1 |
| activated partial prothrombin time | preoperative day 1 |
| activated partial prothrombin time | postoperative day 1 |
| fibrinogen concentration | preoperative day 1 |
| fibrinogen concentration | postoperative day 1 |
| D012216 |
| Rheumatic Diseases |